Cite

MLA Citation

    Zhe Tang et al.. “Advantage of Sorafenib Combined with Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma.” Tumori, vol. 103, no. 3, 2017, pp. 286–291. http://access.bl.uk/ark:/81055/vdc_100072995473.0x000012
  
Back to record